Abstract

Source Citation Mark DB, Hlatky MA, Califf RM, et al. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N ...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Pitfalls in the economic evaluation of thrombolysis in myocardial infarction. The impact of national differences in the cost of thrombolytics and of differences in the efficacy across patient subgroups.
R Lorenzoni
European heart journal | VOL. 19
R LorenzoniR Lorenzoni
01 Oct 1998
Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.
Daniel B Mark ... Robert M Califf
New England Journal of Medicine | VOL. 332
Daniel B Mark, et. al.Daniel B Mark ... Robert M Califf
01 Jan 1995
Primary Prevention of Sudden Cardiac Death
Eric N Prystowsky
Circulation | VOL. 109
Eric N PrystowskyEric N Prystowsky
01 Mar 2004
Should living donor liver transplantation be part of every liver transplant program?
Zakiyah Kadry ... Pierre-Alain Clavien
Journal of Hepatology | VOL. 43
Zakiyah Kadry, et. al.Zakiyah Kadry ... Pierre-Alain Clavien
13 May 2005
View more papers

More From: ACP Journal Club

Paper Title
Journal
Date
Author
Heparin prophylaxis did not increase mortality and was beneficial in adults with sepsis receiving drotrecogin alfa
Deborah Cook
ACP Journal Club | VOL. 148
Deborah CookDeborah Cook
01 Mar 2008
Review: Long-acting inhaled therapies and pulmonary rehabilitation are effective in stable COPD
Christine Mcdonald
ACP Journal Club | VOL. 148
Christine McdonaldChristine Mcdonald
01 Mar 2008
Review: Calcium supplementation, with or without vitamin D, prevents osteoporotic fractures in people ≥ 50 years of age
Sophie A Jamal ... Helen Emanoilidis
ACP Journal Club | VOL. 148
Sophie A Jamal, et. al.Sophie A Jamal ... Helen Emanoilidis
01 Mar 2008
Pharmacogenetic-guided and standard dosing did not differ for out-of-range INRs in patients initiating warfarin therapy
David Garcia
ACP Journal Club | VOL. 148
David GarciaDavid Garcia
01 Mar 2008
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.